Abstract:Background: Helicobacter pylori (H. pylori) infection may be a protective effect against inflammatory bowel disease (IBD). The previous meta-analysis was flawed. This study integrated epidemiological data and rearranged a meta-analysis to identify the correlation between IBD and H. pylori. Moreover, whether IBD medication and classification affecting H. pylori infection, and whether H. pylori eradication leading to recurrence of IBD were analyzed in this study. Methods: Articles published until May 1, 2019, in the PubMed, MEDLINE and Embase databases were searched. Spearman correlation analysis and meta-analysis were performed after collecting and collating the relevant data. Sensitivity analysis and meta-regression were used to evaluate the reliability and sources of heterogeneity. Findings: 59 studies of IBD prevalence, 127 studies of H. pylori prevalence, and 23 studies for meta-analysis were included. IBD, Crohn's disease (CD) and ulcerative colitis (UC) was negatively correlated to H. pylori prevalence respectively (p<0.001, p<0.001, p<0.001). In addition, meta-analysis results showed that IBD, CD and UC were 0.44, 0.36, 0.54 times more likely to have H. pylori infection compared to controls (OR=0.44, 95% CI=0.34-0.59; OR=0.36, 95% CI=0.26-0.49; OR=0.54, 95% CI=0.4-0.72). Moreover, IBD patients were 1.41 times (OR=1.41, 95% CI=1.25-1.58) more likely to relapse after H. pylori eradication compared to no H. pylori eradication. Finally, H. pylori infection was not related to IBD medication and classification. Interpretation: H. pylori prevalence was negatively correlated to IBD and H. pylori was a protective effect against IBD. Furthermore, H. pylori eradication can lead to the recurrence of IBD. Funding Statement: This work was supported by the National Natural Science Foundation of China [grant number 81700485, 81600414, 81600447]. Declaration of Interests: The authors declare there is no conflict of interest regarding the publication of this paper. Ethics Approval Statement: The work was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.

Meta‐analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease

Meta‐analysis: Risk of lymphoma in patients with inflammatory bowel disease in population‐based cohort studies

Inflammatory Bowel Disease and Long-term Risk of Cancer: A Prospective Cohort Study among Half a Million Adults in UK Biobank

The Elevated Risk of Recurrent Clostridioides Difficile Infection in Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-analysis.

The Elevated Risk of Recurrent Clostridioides Difficile Infection in Patients with Inflammatory Bowel Disease: a Systematic Review and Meta-analysis

Is Gallstone disease associated with inflammatory bowel diseases? A meta‐analysis

Association between inflammatory bowel disease and pancreatic cancer: results from the two-sample Mendelian randomization study

Increased Risk of Herpes Zoster Infection in Patients with Inflammatory Bowel Disease: a Meta-Analysis of Cohort Studies

Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-analysis

Inflammatory bowel disease and risk of Parkinson’s disease: evidence from a meta-analysis of 14 studies involving more than 13.4 million individuals

The Risk of Parkinson’s Disease in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study.

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

Causal association between inflammatory bowel disease and acute pancreatitis: a two-sample bidirectional mendelian randomization study

Association between inflammatory bowel disease and the risk of parenteral malignancies: A two-sample Mendelian randomization study

Irritable Bowel Syndrome and Long-Term Risk of Cancer: A Prospective Cohort Study Among 0.5 Million Adults in UK Biobank

The Association Between Periodontitis and Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

The Relationship between Helicobacter pylori and Inflammatory Bowel Disease Based on Epidemiological Data: A Systematic Review and Meta-Analysis

Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations

A Population-Based Matched Cohort Study of Digestive System Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease

Crohn disease but not ulcerative colitis increases the risk of acute pancreatitis: A 2-sample Mendelian randomization study